Hikma Flumazenil Injection USP, 0.1 mg/mL — 10 mL Multi-Dose Vial

Flumazenil Injection, USP is a benzodiazepine-receptor antagonist supplied as a sterile solution for intravenous administration. Each mL contains flumazenil 0.1 mg; this 10 mL multi-dose vial contains 1 mg total. The formulation contains methylparaben 1.8 mg/mL and propylparaben 0.2 mg/mL as preservatives, along with sodium chloride, edetate disodium, and acetic acid. Flumazenil is indicated for complete or partial reversal of the sedative effects of benzodiazepines in appropriate procedural and overdose settings, as described in the prescribing information. It does not reverse opioids, barbiturates, ethanol, or general anesthetics. This item is one 10 mL multi-dose vial distributed by Hikma Pharmaceuticals USA. NDC 0143-9783-01. Store at 25°C (77°F), with permitted excursions from 15°C to 30°C (59°F to 86°F). Rx only. Refer to the current prescribing information for complete indications, contraindications, seizure-risk warnings, precautions, dosing, and administration.